Evidence map›Paper›PMID 33953778›Full record

ArticleResearch in pharmaceutical sciences2021

Protective and therapeutic effects of ethanolic extract of

Sanaz Ramezani, Iraj Javadi, Esmaeel Panahi Kokhdan, Navid Omidifar, Jafar Nikbakht, Heibatollah Sadeghi, Amir Hossein Doustimotlagh, Nazanin Danaei, Reza Abbasi, Hossein Sadeghi

Open access · goldAbstract read
In one paragraph

Article in Research in pharmaceutical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Watercress (Life (Basel, Switzerland) · 2025
    Review
  3. Investigating the effect aerials part ofInternational journal of burns and trauma · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A Review of Antibiotic Efficacy in COVID-19 Control.Journal of immunology research · 2023
    Review
  11. Article
  12. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  13. The Hydroalcoholic Extract ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  14. Effect of ethanolic extract ofResearch in pharmaceutical sciences · 2021
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sanaz RamezaniDepartment of Toxicology, Shahreza Branch, Islamic Azad University, Shahreza, I.R. Iran.
Iraj JavadiDepartment of Toxicology, Shahreza Branch, Islamic Azad University, Shahreza, I.R. Iran.
Esmaeel Panahi KokhdanMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Navid OmidifarClinical Education Research Center, Department of Pathology, Medical School, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Jafar NikbakhtMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Heibatollah SadeghiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Amir Hossein DoustimotlaghMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Nazanin DanaeiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Reza AbbasiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Hossein SadeghiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Yasuj University of Medical Sciences · IRIslamic Azad University of Shahreza · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposePulmonary fibrosis is a chronic disease of the lungs caused by inflammation, species of reactive oxygen, and immune defects. Antioxidant properties of EXPERIMENTAL APPROACH: Forty adult male Wistar rats (180-220 g) were randomly divided into 5 experimental groups. Normal control, BLM control received a single dose of BLM (6 IU/kg) intratracheally only on the first day, EENO + BLM group received EENO (500 mg/kg) one week before intratracheal BLM instillation and two weeks afterward, BLM + EENO group and BML + vitamin E group received EENO (500 mg/kg) and vitamin E (500 mg/kg) half-hour after BLM installation, respectively. The animals were sacrificed on day 22. Change in body weight, lung index, serum level of malondialdehyde (MDA) and nitric oxide (NO) metabolite, lung tissue hydroxyproline content and lung pathology were assessed. FINDINGS/

resultsPre- or post-treatment with EENO attenuated pulmonary fibrosis as evidenced by normalized lung index, improved histological changes and inhibited collagen deposition (hydroxyproline) in the animal lung. EENO also decreased MDA and NO metabolite release in comparison to the BLM control. vitamin E (500 mg/ kg) also significantly inhibited the BLM-induced lung toxicity. CONCLUSIONS AND IMPLICATIONS: EENO can prevent BLM-induced lung fibrosis in rats

Indexed as

BleomycinFibrosisNasturtium officinaleVitamin E

Identifiers

PMID33953778
PMCPMC8074801
OpenAlexW3114066030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.